Alopecia Areata
📧 Sign up to get email alerts when something new happens for Alopecia Areata.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata [Phase 2]
A Phase 2 study evaluating DAXDILIMAB for moderate-to-severe Alopecia Areata has completed and posted results.
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic
A Czech Republic clinical study on the epidemiology, management, and comorbidity patterns of alopecia areata has completed.
-
CLINICAL_TRIALS withdrawal · 2024-10-28Clinical Trial Update: Topical Crisaborole in Patients with Alopecia Areata [Phase 2]
A Phase 2 trial evaluating topical crisaborole for alopecia areata has been withdrawn from the study.
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata [Phase 2]
Phase 2 study evaluating the durability of response to CTP-543 in adults with moderate to severe Alopecia Areata; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age [Phase 1]
Phase 1 study evaluating ritlecitinib for severe alopecia areata in children aged 6 to under 12 has completed, with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Efficacy and Safety of JAK Inhibitors in Patients With AA: RWE Study
A real-world evidence study assessing efficacy and safety of JAK inhibitors in patients with Alopecia Areata, currently recruiting.
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areata [NA]
This clinical trial is recruiting to compare intralesional triamcinolone versus Candida albicans antigen for Alopecia Areata.
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Retinol Binding Protein 4 Protein in Alopecia Areata Treated With Barcitinib [Phase 1]
Phase 1 clinical trial evaluating Barcitinib for alopecia areata; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: A Novel Formulation of Sildenafil-loaded Nanocarriers for Treatment of Alopecia Areata [EARLY_Phase 1]
A Phase 1 trial evaluated a sildenafil-loaded nanocarrier formulation for alopecia areata, and the study has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata [Phase 2]
Phase 2 trial evaluating oral etrasimod for adult moderate-to-severe alopecia areata has completed with results posted.
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: Evaluation of the Efficacy of Systemic Treatments for Alopecia (ESTAA)
This document reports a clinical trial update evaluating systemic treatments for alopecia areata; no results or current status are provided.
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata [Phase 3]
Phase 3 study of baricitinib in adults with severe or very severe alopecia areata completed; results posted.
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: A Phase 2 Placebo Controlled, Clinical Trial Designed to Assess the Efficacy, Safety and Dose Response Characterisation of STS01 for the Treatment of Mild-moderate Alopecia Areata (AA) [Phase 2]
A Phase 2 placebo-controlled trial evaluating STS01 for mild-to-moderate alopecia areata has completed.
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata [Phase 4]
A Phase 4 clinical trial compares topical simvastatin with a topical steroid for alopecia areata, sponsored by Assiut University; the study …
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata [Phase 1, Phase 2]
Clinical trial update for topical jaktinib hydrochloride cream in alopecia areata in Phase 1/2; status unknown.
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi. [Phase 3]
A Phase 3 clinical trial evaluated the efficacy of oral tofacitinib for moderate to severe alopecia areata, including alopecia totalis and u…
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: Needle-free Delivery of Intralesional Triamcinolone for Pediatric Alopecia Areata [Phase 4]
Phase 4 trial update on needle-free delivery of intralesional triamcinolone for pediatric alopecia areata; study terminated with results pos…
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of farudodstat versus placebo in adults with alopecia areata.
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Efficacy and Safety of LH-8 in Paediatric Alopecia Areata [Phase 2, Phase 3]
Phase 2/3 trial results report on the efficacy and safety of LH-8 for pediatric alopecia areata, completed.
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata [NA]
Pilot study evaluating the safety and efficacy of apremilast in adults with moderate to severe Alopecia Areata has completed and posted resu…
-
CLINICAL_TRIALS trial_result · 2023-09-05Clinical Trial Update: Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata [Phase 3]
Phase 3 clinical trial evaluating SHR0302 for efficacy and safety in adults with severe alopecia areata.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2) [Phase 3]
A phase 3 study evaluating the efficacy and safety of CTP-543 in adults with moderate to severe alopecia areata has completed and posted res…
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Efficacy of Oral Apremilast in the Treatment of Alopecia Areata at the Tertiary Care Hospital, Karachi. [Phase 4]
Phase 4 trial update evaluating the efficacy of oral apremilast for alopecia areata completed at a tertiary care hospital in Karachi.
-
FDA approval · 2023-06-23FDA Approved: LITFULO — Original Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved Litfulo (ritlecitinib) from Pfizer as an original application, marking the first approval of this JAK inhibitor for alopeci…
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1) [Phase 3]
Phase 3 trial THRIVE-AA1 evaluating CTP-543 for efficacy and safety in adults with moderate to severe alopecia areata has completed; results…